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http://www.biomedcentral.com/1471-2458/14/205RESEARCH ARTICLE Open AccessIncidence rates of sickness absence related to
mental disorders: a systematic literature review
Carolyn S Dewa1,3*, Desmond Loong1, Sarah Bonato2 and Hiske Hees4,5Abstract
Background: Over the past decade, growing attention has been given to the mental health of workers. One way
to examine the mental health of workers is to look at the incidence rates of mental illness-related sickness absence.
There is a scarcity of literature in which the incidence rates of mental illness-related sickness absence among
different countries have been considered together. The purpose of this systematic literature review is to address the
question: Are there similarities and differences in the incidence rates of mental disorder-related sickness absence
among and within OECD identified Social Democratic, Liberal and Latin American country categories? In this paper,
we seek to identify differences and similarities in the literature rather than to explain them. With this review, we lay
the groundwork for and point to areas for future research as well as to raise questions regarding reasons for the
differences and similarities.
Methods: A systematic literature search of the following databases were performed: Medline Current, Medline
In-process, PsycINFO, Econlit and Web of Science. The search period covered 2002–2013. The systematic literature
search focused on working adults between 18–65 years old who had not retired and who had mental and/or
substance abuse disorders. Intervention studies were excluded. The search focused on medically certified sickness
absences.
Results: A total of 3,818 unique citations were identified. Of these, 10 studies met the inclusion/exclusion criteria;
six were from Social Democratic countries. Their quality ranged from good to excellent. There was variation in the
incidence rates reported by the studies from the Social Democratic, Liberal and Latin American countries in this
review.
Conclusions: The results of this systematic review suggest that this is an emerging area of inquiry that needs to
continue to grow. Priority areas to support growth include cross jurisdictional collaboration and development of a
typology characterizing the benefit generosity and work integration policies of sickness absence schemes. Finally,
the literature should be updated to reflect changes in sickness absence benefit schemes over time.
Keywords: Sickness absence, Mental disorders, IncidenceBackground
Global focus on worker mental health
Over the past decade, increasing attention has turned to
the mental health of workers and its effects on the
workplace. For example, European Ministers of Health
have advocated that employers include mental health
programs as part of occupational health and safety [1].* Correspondence: carolyn.dewa@camh.ca
1Centre for Research on Employment and Workplace Health, Centre for
Addiction and Mental Health, 33 Russell Street, Toronto M5S 2S1, Canada
3Department of Psychiatry, University of Toronto, 250 College Street, Toronto
M5T 1R8, Canada
Full list of author information is available at the end of the article
© 2014 Dewa et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orSimilar endorsements have been made in Australia [2],
the United States [3] and Canada [4].
The impetus for greater attention to worker mental
health has also been spurred by a growing awareness of
the impact of mental disorders on the workplace. Indeed,
an expanding body of literature indicates that mental ill-
ness takes its workplace toll in the form of work absences
and decreased productivity (e.g., [5-7]). Because of the
length of their absences [8-12] and their rates of recur-
rence [10,13-15], sickness absences related to mental ill-
ness are one of the most costly types of sickness absences.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Importance of incidence rates of mental illness-related
sickness absence
One way to examine the mental health of workers is to
look at the incidence rates of mental illness-related sick-
ness absence. That is, the better the mental health status
of workers, the lower the incidence rates of mental illness-
related sickness absence. But, because there are differences
in the way various countries approach the mental health
of their working populations [16], it could be useful to
consider incidence rates by jurisdictions. Jurisdictions with
higher rates might be places where further exploration
could take place to identify the types of approaches to
avoid. In contrast, those with lower rates may be places
where further studies could be conducted to learn about
effective practices.
Considering country variations
One of the challenges of examining the rates of sickness
absence incidence among countries is related to the het-
erogeneity of country system factors that affect workers.
Examples of these system factors include country work
integration policies such as employer sickness absence
obligations, employment rehabilitation programs and work
incentives. Another group of factors is related to country
compensation policies such as the population covered, dis-
ability benefit eligibility and criteria.
Recognizing the heterogeneity among countries, the
Organization for Economic Co-operation and Develop-
ment (OECD) developed a classification system to be used
to understand the similarity among countries with respect
to their work integration and worker compensation pol-
icies. The classification builds on work from the political
economy literature that was developed to compare social
policies across diverse jurisdictions (e.g., [17-19]). The
classification focuses on the types of public policies (e.g.,
work integration schemes) that would affect work-related
outcomes (e.g., employment rates) [20]. The classification
system facilitates discussion without becoming entrenched
in the complexities of individual systems [19].
The OECD [16] examined the disability policies of 15
OECD countries. Disability policies were evaluated based
on the generosity of their compensation and the extent
of their work integration policies. The OECD [16] catego-
rized countries into three main groups: (1) Social Demo-
cratic, (2) Liberal and (3) Corporatist.
Social Democratic countries were characterized as being
relatively the most generous and having the most exten-
sive work integration policies. These countries include
Finland, Denmark, the Netherlands, and Norway. In con-
trast, the Liberal countries were characterized as being
relatively the least generous and with the least extensivework integration policies. Countries in this category are
the United Kingdom, the United States and Canada.
Corporatist countries are characterized being relatively
moderate – they were not as generous as the Social
Democratic countries but not as conservative as the
Liberal countries with respect to benefits and work inte-
gration policies. These countries include Austria, Belgium,
and France.
Because they are emerging welfare states, the Latin
American countries generally are treated as a unique
cluster [21,22].
Gap in the literature
There is a scarcity of literature in which the incidence
rates of mental illness-related sickness absence among
different countries have been considered together. Part
of this gap in the literature may reflect the challenge intro-
duced by the heterogeneity with which countries approach
sickness absence. The OECD classification system offers a
way to describe systemic similarities and differences
among countries. In turn, this information can be used as
a first step toward studying effective systemic practices.
The purpose of this systematic literature review is to take
this first step. We address the question: Are there simi-
larities and differences in the incidence rates of mental
disorder-related sickness absence among and within
OECD categories? In this paper, we seek to identify dif-
ferences and similarities rather than to explain them.
With this review, we lay the groundwork for and point
to areas for future research. In doing so, we also raise
questions regarding reasons for the differences and
similarities.
Methods
For the purposes of this systematic review, five electronic
databases were searched. They included: (1) Medline
Current (an index of journal articles in biomedical re-
search and clinical sciences), (2) Medline In-process (an
index of journal articles in biomedical research and clinical
sciences that are awaiting indexing into Medline Current),
(3) PsycINFO (an index of journal articles, books, chapters,
and dissertations in psychology, social sciences, behavioral
sciences, and health sciences), (4) Econlit (an index of
journal articles, books, working papers and dissertations
in Economics) and (5) Web of Science (an index of journal
articles, editorially selected books and conference proceed-
ings in life sciences and biomedical research). A search
strategy was developed and executed for each database
with the help of a professional health science librarian
(SB). Medline Current, Medline In-process and PsycINFO
were searched using the OVID platform. Econlit and
Web of Science were searched using the ProQuest and
Thomson Reuters search interface, respectively. The
search was completed between February 2013 and
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nals published between 2002 and 2013. The complete
search strategy used for each database can be found in
Appendix 1.
Eligibility criteria
The systematic literature search focused on working
adults between 18–65 years old who had not retired and
who had mental and/or substance abuse disorders. Inter-
vention studies were excluded. The search focused on
medically certified sickness absences that included sick
leave, short-term disability leave, long-term disability leave
or sickness absence. For the purposes of this review, sick-
ness absence was defined as a work absence requiring a
medical certification. These income replacement or disabil-
ity benefits (i.e., short-term or long-term work disability)
could be either publicly or privately sponsored. In terms
of cause of disability, we focused our search on “no cause”
disability leaves. That is, the worker did not need to prove
that the disability was caused by work.
All search results were screened by title, followed by
abstract and full-text review for relevant articles. The
reference lists of the articles that made it to the full-text
review stage were also hand-searched. The screening
process was completed independently by two reviewers,
CSD and DL, using the following eligibility criteria:
1. The study reported on medically certified sickness
absences due to mental illness and/or addiction
problems.
2. The study reported the incidence of medically
certified sickness absences due to mental illness and/
or addiction problems.
3. The study analyzed data collected in the year 2000
or later.
4. The study sample was not from a select population
(i.e. clinical trial, clinical populations).
The year 2002 was used as the starting point for inclu-
sion because the 1990s were a period of global change in
employment policies [23]. Thus, we focused on the last
decade because during this time, there were relatively
fewer policy changes related to workers. Because pre-2000
data were collected under systems that existed before
the policy changes of the 1990s, studies that used pre-
2000 data were also excluded.
Discussions were held in instances where there were
disagreements until consensus was reached. The inter-
rater reliability which corrected for chance agreement
was calculated for CSD and DL to be 0.93. Review arti-
cles and commentaries were excluded when possible
during the screening process. Consensus regarding the
inclusion of the final articles was reached among
CSD, DL and HH.Quality assessment
Articles that passed the three-stage screening process
were assessed for quality using the following criteria:
1. The study population is well described.
2. The data source is well described.
3. The study sample is representative of the target
population.
4. Mental disorders are included and reported.
5. The system of diagnosis/classification is described.
6. The criteria for sickness absence is reported (i.e.,
pre-sickness absence days to qualify for sickness
absence).
7. The denominator is clearly reported.
8. The numerator is clearly reported.
9. Uncertainty of estimates is reported.
10. The stated research objective is met.
One point was awarded for each met criterion for a
maximum score of 10. Scores between 1 and 4 were
regarded as ‘fair/weak’ quality and scores between 5
and 8 were ‘good’. Scores of 9 and 10 were regarded as
‘excellent’ quality.
Results
Description of inclusion and exclusion
The electronic literature search resulted in the identifi-
cation of 3,818 unique citations (Figure 1). From these,
24 entries that were commentaries were excluded. Based
on the title review, 3,524 citations were excluded. Based
on the abstract review, another 160 citations were ex-
cluded; this left 110 articles for full-text review. After the
full-text review, 10 articles remained. Reasons for article
exclusion included: (1) did not have information about
medically certified sickness absence related to mental
disorders (n = 33), (2) were based on select populations
(n = 13), (3) used pre-2000 data (n = 3), (4) did not report
incidence rates from medically certified sickness absence
related to mental disorders (n = 49) and (5) the study
population did not consist of adults eligible for sickness
absence (e.g., the study population included people who
were not employed) (n = 2).
The 10 included studies were conducted in countries
that clustered into three country types: (1) Social Demo-
cratic (n = 6), (2) Liberal (n = 1) and (3) Latin America
(n = 3). The Social Democratic category included studies
from Norway, Finland and the Netherlands. The study
in the Liberal category was from Canada. Finally, all the
Latin American studies were from Brazil.
Quality assessment
The quality assessment rated three of the 10 studies as
excellent and the remaining seven as good (Additional
file 1: Table S1, Additional file 2). The identified
Abstracts retrieved 
(n = 270) 
Unique citations identified 
through database and hand 
search
(n = 3818)
Commentaries Excluded 
(n = 24) 
Total studies screened 
(n = 3794) 
Excluded based on title 
(n = 3524) 
Excluded based on abstract 
(n = 160) 
Full-text articles retrieved
(n = 110) 
Excluded based on  
full-text (n=100) 
Studies assessed for quality 
(n = 10) 
Excluded based on  
quality (n = 0) 
Excellent
(n =3) 
Good
(n = 7) 
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Figure 1 Flowchart of literature search results and inclusions/exclusions.
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was not representative of the target population (8 studies),
uncertainty of the incidence rate estimate was not re-
ported (4 studies) and the stated research objective was
not met (3 studies).Overview of the studies
Table 1 contains the descriptions of the included studies.
All of the included studies used administrative data from
either an insurer or healthcare group practice. As a result,
all of the studies represented identifiable complete popula-
tions of people at risk of having a sickness absence anddata were either from their sickness absence insurer, work-
place or healthcare provider.
With the exception of one of the studies, which used
the International Classification of Primary Care (ICPC),
the studies used the International Classification of
Diseases 10th edition (ICD-10). However, Virtanen et al.’s
[24] study also reported the ICD-10 equivalents to the
ICPC.
There was variability among the included studies with
respect to the primary diagnoses of the sickness absence
cases that were included in the analyses. However, there
were also similarities; all studies included absences re-
lated to depressive, anxiety and stress-related disorders.
Table 1 Description of individual studies
Author(s) Country Study population Data source Year(s)
of data
Diagnostic
classification
system used
Absence days to qualify for
sickness absence benefit
Social democratic
Virtanen et al. [24] FI
Participants from the Finnish Public Sector Study covering
employees in 10 towns and 21 public hospitals in Finland;
who were not on long-term sick leave or disability
pension at the time of the survey; and who were
employed for at least 6 months during the study
between 1997-2005
Administrative data from the National
Health Insurance, employer records and
national health register records and the
Finnish Public Sector Study
1997-2005
International
Classification of
Diseases,10th
edition (ICD-10)
Long-term sickness absence =
sickness absence of ≥ 90 days
Roelen et al. [28] NL
Employees of firms who were clients of an occupational
health services provider from 2001-2007
Administrative sickness absence data
from ArboNed
2001-2007 ICD-10
Sickness absence: absence
of ≥ 28 sick days requiring a
medical certificate from an
occupational physician
Koopmans et al. [26] NL
Dutch Post and Telecommunication employees from
2001-2007
Administrative sickness absence data
from ArboNed
2001-2007 ICD-10
Sick leaves of > 3 weeks
require a medical certificate
from an occupational
physician
Roelen et al. [27] NL
Dutch Post and Telecommunication employees from
2001-2007
Administrative sickness absence data
from ArboNed
2001-2007 ICD-10
Sick leaves of > 3 weeks
require a medical certificate
from an occupational
physician
Roelen et al. [29] NL
Employees covered in a sickness absence benefit
program from 2001-2010
Administrative sickness absence data 2001-2010 ICD-10
Sickness absence = absence
of > 3 weeks requiring a
medical certificate from an
occupational physician
Hensing et al. [25] NO
People who were 16–66 years in 1994, 1996, 1998 and
2000 who were compulsory members of the Sickness
Benefit Scheme
Administrative data from the Norwegian
National Sickness Administration
1994, 1996,
1998, 2000
International
Classification of
Primary Care
(ICPC)
Medical certification is
required for sick
leave > 4 days
Liberal
Dewa et al. [11]
CA
(Ontario)
Employees from a large resource sector company from
2003-2006
Administrative sickness absence data 2003-2006 ICD-10
Sickness absence = sickness
absence of > 5 continuous
work days requiring a medical
certificate
Latin America
Barbosa-Branco
et al. [32]
BR All employees registered in private sector jobs in 2008
Administrative data from health
service provider
2008 ICD-10
Sickness absence = ≥ 15
consecutive days absent
requiring a medical certificate
Reis et al. [30] BR
Workers from a university hospital who were employed
from 2000-2007
Administrative data from health
service provider
2000-2007 ICD-10 Not described
Barbosa-Branco
et al. [31]
BR All employees registered in private sector jobs in 2008
National Benefits System and National
Social Information Database
2008 ICD-10
Sickness absence = ≥ 15
consecutive days absent
requiring a medical certificate
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ies with regard to a core set of mental disorders.
There was variability in the number of absence days
needed to qualify for sickness absence benefits. The
number of qualifying days used for the studies ranged
from 3 days to 90 days. It should be noted, that while
the days required to qualify for benefits in Finland is
9 days, due to limited availability of the data, the Finnish
study [24] examined the incidence of sickness absences
that were >90 days.
Numerators: measures of sickness absence rates
In general, the studies used two types of incidence mea-
sures. The first type of measure reported the incidence
of workers with sickness absence. That is, either only
the first episode or the worker who had an episode was
counted.
In contrast, the second type of measure reported the
incidence of sickness absences. It counted the number of
episodes occurring in a defined time period. Thus, if a
person had more than one sickness absence during the
time period of interest, s/he was counted as many times
as there was a discrete sickness absence.
Cohorts: measures of sickness absence rates
Among the included studies, two types of cohorts were
used. One was a 1-year cohort. It included people who
were at risk of a sickness absence during a 12-month
period. The other was a dynamic cohort for which mul-
tiple years of data were used such that the denominator
was calculated with the number of workers at risk of
sickness absence in terms of either worker-years or
worker-months.
Reported incidence rates
Social democratic countries
Using year 2000 administrative data from the national
sickness administration, Hensing et al. [25] observed
that the age-adjusted cumulative incidence of men with
sickness absence ranged from 0.9/1,000 workers for
psychosis-related absences to 13/1,000 for depression-
related absences (Table 2). In contrast, for women, the
cumulative incidence rates ranged from 1/1,000 for
psychosis-related absences to 30/1,000 for depression-
related absences.
Virtanen et al. [24] used linked data from 1997–2005
and reported the cumulative incidence of long-term
sickness absence that ranged from 2/1,000 for absences
related to schizophrenia and schizotypal and delusional
disorders to 19/1,000 for absences related to depression.
Using data from 2001–2007 from one organization
with a nation-wide employee base, Koopmans et al. [26]
reported an incidence density of 21.8/1,000 worker-years
for common mental disorders (CMD) among men and31.5/1,000 among women. Using a similar dataset, Roelen
et al. [27] observed an incidence density of 27.7/1,000
worker-years for mental and behavioral disorders.
Based on data from an occupational health service
provider, Roelen and colleagues [28] calculated the 12-
month incidence rates for sickness absences related to
CMD from 2001–2007. During that time period, it ap-
peared that 12-month incidence rates related to CMD
ranged from a high of 27/1,000 employees in 2003 and
2004 to 20/1,000 employees in 2007. In a separate
study, Roelen et al. [29] estimated that 12-month inci-
dence rates related to mental and behavioral disorders
ranged from 21.1/1,000 employees in 2001 to 17.7/1,000
employees in 2010.
Liberal countries
Based on data from one organization with a province-wide
employee base, Dewa et al. [11] reported a rate of 21/1,000
worker-years for sickness absences related to mental
disorders. When stratified by sex, the incidence rate for
men was 17/1,000 worker-years and 36/1,000 worker-
years for women.
Latin America
All of the Latin American studies in this review were
from Brazil. Using 2000–2007 data from one university
hospital, Reis and colleagues [30] reported an incidence
density of 0.33/100 worker-months or approximately
39.6/1,000 worker-years. Based on 2008 national data of
private sector companies, Barbosa-Branco et al. [31,32]
observed an incidence rate of 45.1/10,000 or 4.5/1,000
workers. For specific mental disorders, incidence rates
varied by primary disorder from 15.4/10,000 workers
(1.5/1,000) for sickness absences related to depression
and 2.8/10,000 (0.3/1,000) workers for reaction to severe
stress.
Discussion
The quality ratings of included studies ranged from good
to excellent. There was variation in the incidence rates
reported by the studies from the Social Democratic,
Liberal and Latin American countries in this review. For
the studies conducted in the Social Democratic countries,
the incidence rates of sickness absences related to mental
disorders ranged between 19 and 28/1,000 workers or
1,000 worker-years. In contrast, the incidence rate re-
ported by the study from the Liberal country was 21/1,000
workers. In addition, there was variation in the rates
reported by the studies from the Latin America and
ranged from 2 - 40/1,000 workers.
The differences reported raise a number of questions.
Are they a reflection of the differences in system struc-
tures? For instance, among countries in which there is
relatively more government involvement (i.e., Social
Table 2 Results of individual studies
Author(s) Country Mental disorders Measure Denominator Numerator Reported incidence
Social democratic
Virtanen
et al. [24]
FI
Mental and behavioral disorders including:
depressive disorders, mania and bipolar affective
disorder, anxiety disorders (phobias, panic disorder,
obsessive compulsive disorder and generalized
anxiety disorder), reaction to severe stress and
adjustment disorders, personality disorder,
schizophrenia, schizotypal and delusional disorders
and mental and behavioral disorders due to
psychoactive substance use (ICD-10 Chapter F)
Study participants followed for an
average of 6.3 years n = 141,917
Depressive
disorder = 2,679
Cumulative incidence of
disability benefit receipt:
Depressive disorders = 1.9%
Cumulative incidence
Mania and
bipolar affective
disorder =150
Mania and bipolar
affective disorder = 0.1%
Anxiety
disorder = 314
Anxiety disorder = 0.2%
Reaction to severe
stress and adjustment
disorders = 275
Reaction to severe stress and
adjustment disorders = 0.2%
Adult personality
and behaviour
disorders = 54
Adult personality and
behaviour disorders = 0.04%
Schizophrenia and
schizotypal and delusional
disorder = 283
Schizophrenia and schizotypal
and delusional disorder = 0.2%
Mental and behavioural
disorders owing to
psychoactive substance
use = 62
Mental and behavioural
disorders owing to
psychoactive substance
use = 0.04%
Roelen
et al. [28]
NL
Common mental disorders (CMD) included distress
(ICD-10 R45), other stress-related disorders
(ICD-10 F43), depressive disorders (ICD-10 F32)
and anxiety disorders (ICD-10 F40 and F41)
Total Employees: Number of episodes:
12-month incidence of
sickness absence for CMD by
year/100 employees (95% CI):
Dynamic cohort study 12-month
incidence of total certified sickness
absence = number of medically certified
sickness absence episodes/number of
employees covered
2001 = 956,623 2001 = 21,140 2001 = 2.2 (2.2, 2.2)
2002 = 962,235 2002 = 22,803 2002 = 2.4 (2.3, 2.4)
2003 = 937,030 2003 = 24,917 2003 = 2.7 (2.6, 2.7)
2004 = 1,037,149 2004 = 27,533 2004 = 2.7 (2.6, 2.7)
2005 = 961,890 2005 = 22,682 2005 = 2.4 (2.3, 2.4)
2006 = 970,390 2006 = 20,013 2006 = 2.1 (2, 2.1)
2007 = 921,741 2007 = 18,513 2007 = 2 (2, 2)
Koopmans
et al. [26]
NL
Common mental disorders (CMD) from medical
certification: stress-related (distress and adjustment
disorders) (ICD-10 R45, F43) and psychiatric (mild
to moderate depressive and anxiety disorders)
(ICD10 F32.0, F32.1, F40.0, F40.1, F40.2, F41.0, F41.1,
F41.2, F41.3)
Dynamic cohort study
Number of
employees =
137,172
From 2001–2007, CMD
densities/1,000 worker-years
(95% CI):
Index episode = one episode during
research period
Worker-years =
363,461
Men: Men:
Incidence density of index episodes = # of
employees with a first episode of sickness
absence due to CMDs between 2001 and
Stress = 4,704 Stress = 19.7 (19.1, 20.2)
Psychiatric = 723 (2.8, 3.2) Psychiatric = 3.0 (2.8, 3.2)
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Table 2 Results of individual studies (Continued)
2007/worker-years of the total population
at risk
Total CMD = 34,603 Total CMD = 21.8 (21.2, 22.4)
Women: Women:
Stress = 3,298 Stress = 27.8 (26.8, 28.7)
Psychiatric = 612 Psychiatric = 5.2 (4.7, 5.6)
Total CMD = 18,026 Total CMD = 31.5 (30.5, 32.5)
Roelen
et al. [27]
NL
Mental and behavioral disorders from medical
certification (ICD-10 F00-F99)
Dynamic cohort
Number of
employees =
137,172
Mental and behavioural
disorders = 7,197
From 2001–2007, incidence
density/1,000 worker-years
Mental and behavioural
disorders (95% CI):
Incidence density = incident episodes of
sickness absence/worker-years at risk
Worker-years =
363,461 Incidence density = 27.7 (27.0,
28.4)
Roelen
et al. [29]
NL
Mental and behavioral disorders from medical
certification: emotional disturbance (ICD-10 R45),
depressive disorders (ICD-10 F32), anxiety disorders
(ICD-10 F40-41) and stress-related disorders
(ICD-10 F43)
Incidence/year
2001 = 956,623
Not described
Incidence of sickness
absence by year/1,000
employees (95% CI):
2001 = 21.1 (20.8, 21.4)
2002 = 962,235 2002 = 22.5 (22.3, 22.8)
2003 = 937,030 2003 = 25.3 (25.0, 25.6)
2004 = 1,037,149 2004 = 25.5 (25.2, 25.8)
2005 = 961,890 2005 = 22.9 (22.6, 23.2)
2006 = 970,390 2006 = 20.0 (19.7, 20.3)
2007 = 913,266 2007 = 20.1 (19.8, 20.4)
2008 = 924,300 2008 = 19.4 (19.1, 19.7)
2009 = 1,033,072 2009 = 16.9 (16.6, 17.2)
2010 = 1,006,861 2010 = 17.7 (17.4, 18.0)
Hensing
et al. [25]
NO
Included: Psychoses (ICD-10 F20-31, F35-39),
anxiety (ICD-10 F40-F43), neurotic conditions
(ICD-10 F44-48, F99), depression (ICD-10 F32-F34),
personality disorders (ICD-10 F60-69), alcohol/drug
abuse (ICD-10 F10-F19)
Cumulative incidence = # of individuals
with ≥ 1 sickness absence episode
initiated in each year studied/# of
individuals entitled to sickness benefits
during that year
Denominator:
Not described
Age-adjusted cumulative
incidence of sickness
absence in 2000 (95% CI):
Men: n = 1,219,338
Women:
n = 1,063,423
Men:
Psychoses = 0.09% (0.09, 0.09)
Anxiety disorders = 0.20%
(0.19, 0.20)
Neurotic conditions = 0.54%
(0.54, 0.54)
Depression = 1.31% (1.29, 1.33)
Personality disorders = 0.01%
(0.01, 0.01)
Excluded: Dementia, organic psychoses, mental
retardation and child and adolescent psychiatry
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Table 2 Results of individual studies (Continued)
Alcohol and drug
disorders = 0.09% (0.09, 0.09)
Women:
Psychoses = 0.10% (0.10, 0.10)
Anxiety disorders = 0.35%
(0.34, 0.35)
Neurotic conditions = 1.11%
(1.09, 1.13)
Depression = 3.01% (3.00, 3.04)
Personality disorders = 0.01%
(0.01, 0.02)
Alcohol and drug
disorders = 0.02% (0.02, 0.03)
Liberal
Dewa
et al. [11]
CA
(Ontario)
Schizophrenia, mood disorders, stress-related
disorders and mental and behavioral disorders due
to psychoactive substance use (ICD-10 F00-F99
and Z502, Z503, Z561-566, Z630-Z639, Z729, Z733,
Z738, Z864 and Z915)
Incidence = Number of sickness absence
episodes/worker-years at risk
n = 12,407
employees
Total = 698
Incidence of disability/100
worker-years (95% CI):
n = 33,028.79
worker-years
Men = 449
Mental disorders:
Women = 249
Total = 2.1 (2.0, 2.3)
Men = 1.7 (1.6, 1.9)
Women = 3.6 (3.2, 4.1)
Latin America
Barbosa-
Branco
et al. [32]
BR
Disorders in the ICD-10 Mental and Behavioral
Disorders Chapter 5
Case = a newly granted sickness absence
claim
n = 32,590,239 Not described
Age and sex standardized
rates of sickness absences
for mental and behavioral
disorders/10,000
workers = 45.1
Cases that were within 60 days of each
other for the same diagnosis were
considered to constitute one case
Incidence = number of sickness benefit
claims due to mental disorders/average
number of workers at risk
Reis
et al. [30]
BR Mental and behavioral disorders (ICD-10 F00-F99)
Incidence density = number of new
sickness absence/total worker-time at risk
for the first sickness absence
n = 1,542 workers n = 324
Mental and behavioral
disorders:
Incidence density/100
worker-months = 0.33
Barbosa-
Branco
et al. [31]
BR
Disorders in the ICD-10 Mental and Behavioral
Disorders Chapter 5
Case = a newly granted sickness absence
claim
n = 32,590,239
Prevalence of sickness
absence claims/10,000
workers:
Cases that were within 60 days of each
other for the same diagnosis were
considered to constitute one case
Any mental
disorder = 147,105
Any mental disorder = 45.1
Depressive
episode = 50,289
Depressive episode = 15.4
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Table 2 Results of individual studies (Continued)
Other anxiety
disorder = 19,508
Other anxiety disorder = 6.0
Incidence = number of sickness benefit
claims due to mental disorders/average
number of workers at risk
Recurrent depressive
episode = 14,524
Recurrent depressive
episode = 4.5
Multiple drug
use = 11,224
Multiple drug use = 3.4
Bipolar affective
disorders = 9,504
Bipolar affective
disorders = 2.9
Reaction to severe
stress = 9,008
Reaction to severe stress = 2.8
Use of alcohol = 8,545 Use of alcohol = 2.6
Schizophrenia = 4,616 Schizophrenia = 1.4
Use of cocaine = 3,468 Use of cocaine = 1.1
Unspecified nonorganic
psychosis = 2,950
Unspecified nonorganic
psychosis = 0.91
Phobic anxiety
disorders = 2,023
Phobic anxiety disorders = 0.6
Unspecified nonorganic
psychosis = 1,794
Unspecified nonorganic
psychosis = 0.6
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http://www.biomedcentral.com/1471-2458/14/205Democratic), the range in the incidence rates is rela-
tively small. The Liberal country group consisted of one
country. Yet, the Liberal countries have the least gov-
ernment involvement in benefit and work integration
schemes. If that is the case, sickness absence rates are
based on definitions of work disability and benefit quali-
fication criteria that depend on private schemes that
could be as varied as they are numerous. Such variation
in schemes could in turn impact the variation in rates.
To further pursue this line of inquiry and to understand
variations within country types, it will be useful if a typ-
ology similar to the OECD’s [16] were developed especially
in countries where there is less government involvement.
In addition to describing countries, such a typology could
characterize sickness absence benefit schemes.
Another question that arises is why there was such
variation among the Latin America studies given they
were all from Brazil? Was it because there are significant
differences in the mental health among workers? Or
are there significant differences in the benefit schemes
(i.e., qualification criteria)? Here, a typology characterizing
the benefit generosity (i.e., the population covered, dis-
ability benefit eligibility and criteria) and work integration
schemes (i.e., employer obligations for sickness absence,
employment rehabilitation programs and work incen-
tives) of individual plans could assist in answering these
questions.
The results also indicate that among the studies that
report incidence rates by sex, there is a trend toward a
higher incidence rate among women than men. This
corroborates findings from Hensing and Wahlstrom’s
[33] systematic review of risk factors associated with
sickness absence. They found evidence suggesting that
women have a higher risk of having an absence related
to mental disorders.
Strengths and limitations related to interpreting the
literature
There were a number of strengths of the current body of
literature reviewed. First, all of the studies represented
identifiable complete populations of people at risk of
having a sickness absence. At the same time, it is im-
portant to note that there was variation in the breadth
of the populations covered from entire countries to sin-
gle organizations. Thus, it will be important for future
work to examine whether the rates reported hold for
larger populations and for different populations within
the same country.
Another strength was that all of the studies used stan-
dardized diagnostic classification systems. All included
depressive and anxiety disorders as well as stress-related
disorders. However, there was variability in the other
type of disorders considered. This could have made
some rates higher than others. At the same time, itshould be noted that the majority of sickness absences
related to mental disorders are attributable to depres-
sion, anxiety and stress-related disorders [34,35]. This
suggests that inclusion of these disorders would capture
a large proportion of the sickness absences related to
mental disorders.
A limitation of the studies was the variation in the
years they captured. Although all studies used post-2000
data, there could have been changes within systems that
could have affected incidence rates. For example, in the
Netherlands, extensive legislative changes occurred be-
tween 2000 and 2013 which affected rates [23,36]. In
fact, the changes are reflected in the rates reported by
Roelen et al. [29]. Similarly, changes could have been
implemented in other countries such that rates could
vary depending on year.
Another limitation was variability in the absence days
cut-offs used. A low number of qualifying days could
have made the rates higher compared to benefit schemes
with a greater number of qualifying days. At the same
time, all schemes required medical certification and an
assessment of work ability. To the extent that symptoms
manifest over several weeks, it may be that workers seek
a sickness absence at similar phases of their mental dis-
order. If the acute phase at which they apply for a sick-
ness absence leave is similar, the actual variation may be
minimized. On the other hand, if there is variation in
when workers seek medical certificates, incidence rates
may be higher in studies where medical certification takes
place in an earlier phase of sickness absence. However, the
results of Roelen et al.’s [29] study did not seem to support
the latter hypothesis. But, this suggests another area for
future inquiry – when do workers apply for sickness
absence?
Strengths and limitations of the search strategy
While five databases were searched, it is possible that an
article could have been missed if it did not appear in any
of the databases. However, that possibility is small given
the broad scope of each of the databases. Another limi-
tation is that the search was limited to English-language
journals. Thus, it did not identify research that was not
published in English. However, it should be noted that
despite the language constraint, the included studies
came from Europe, North America and Latin America.
This suggests that at least some of the researchers from
countries in which English is not a first language are
publishing in English-language journals.
Future directions
Both the causes of and the effective return to work strat-
egies for sickness absences related to mental disorders
are multifactorial and complex [37,38] and extend be-
yond the scope of this paper. Indeed, the results of this
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there differences among country types? Do these differ-
ences truly exist? Or, are they anomalies of the data used?
What role does the sickness absence benefit structure play
in the incidence rates? What is the appropriate benchmark
for sickness absence related to mental disorders?
Cooperation and data sharing among countries as well
as between database holders and researchers could help
to increase the understanding regarding the similarities
and differences of incidence rates. Access to the data
necessary to calculate incidence rates often presents a
challenge [39,40]. Rather than relying on primary data
collection, these types of studies rely on administrative
data. This means that the researchers are often not in-
volved in the dataset design. As a result, the calculation
of incidence estimates is often influenced by the data
limitations. In the future, it would be useful if data
warehouses were created where data necessary for this
type of research were accessible. It would also help to
advance the field if the database managers and researchers
were able to work together to design databases that meet
administrative and research needs. This would help to
promote understanding of incidence rates for a broader
range of workers and increase interpretability of the inter-
national literature.
Conclusions
The results of this systematic review suggest that this is
an emerging area of inquiry that needs to continue to
grow. This review identified only 10 studies that were
published in the last 10 years; four of them came from a
single country. As this literature continues to expand
and if countries are to learn from one another, cross juris-
dictional collaboration should be pursued and supported.
Perhaps, it could begin among countries categorized in
the same OECD category. In addition, as benefit schemes
respond to economic circumstances, it will be important
that this literature be updated to reflect these changes.
Finally, to facilitate a meaningful international dialogue
regarding sickness absence, the development of a typ-
ology characterizing the sickness absence benefit gener-
osity and work integration policies of sickness absence
schemes should be a research priority.
Appendix 1: Search strategy
Database: Medline Current
Search Terms: [exp Mental Disorders/OR exp Mentally
Ill Persons/OR (mental adj3 disorder$).mp. OR (mental$
adj3 ill$).mp. OR (psychiatric$ adj3 disorder$).mp. OR
(psychiatric$ adj3 ill$).mp. OR exp Substance-Related
Disorders/OR exp “Diagnosis, Dual (Psychiatry)”/OR
(concurrent$ adj3 disorder$).mp. OR (dual$ adj3 diag$).
mp. OR (alcohol$ adj3 abus$).mp. OR (alcohol$ adj3
depend$).mp. OR (substance$ adj3 abus$).mp. OR(substance$ adj3 depend$).mp. OR (drug$ adj3 abus$).
mp. OR (drug$ adj3 depend$).mp. OR addiction$.mp.]
AND [exp Absenteeism/OR exp Sick Leave/OR exp
Return to Work/OR exp Personnel Turnover/OR Social
Welfare/OR Public Assistance/OR exp Insurance Disability/
OR exp Insurance Benefits/OR exp Salaries/OR exp Fringe
Benefits/OR exp Social Security/OR exp Retirement/OR
(sick$ adj3 day$).mp. OR (illness$ adj3 leave$).mp. OR
(disabilit$ adj3 leave$).mp. OR (short term disabilit$).
mp. OR (long term disabilit$).mp. OR (work$ adj3 ab-
sence$).mp. OR (return$ to work$).mp. OR (work$ adj3
turnover$).mp. OR (employ$ adj3 turnover$).mp. OR
(disabilit$ benefit$).mp. OR (employ$ benefit$).mp. OR
(work$ benefit$).mp. OR (sick$ benefit$).mp. OR (inca-
pacit$ benefit$).mp. OR (social$ welfar$).mp. OR (pub-
lic$ assistanc$).mp. OR (insurance$ disabilit$).mp. OR
(insurance$ benefit$).mp. OR (old$ age$ assistanc$).
mp. OR (social$ securit$).mp. OR retire$.mp.] AND
[sn.fs. OR ep.fs. OR preval$.mp. OR incid$.mp. OR stat-
istic$.mp. OR exp Epidemiologic Methods/].
Database: Medline In-process
Search Terms: [exp Mental Disorders/OR exp Mentally
Ill Persons/OR (mental adj3 disorder$).mp. OR (mental$
adj3 ill$).mp. OR (psychiatric$ adj3 disorder$).mp. OR
(psychiatric$ adj3 ill$).mp. OR exp Substance-Related
Disorders/OR exp “Diagnosis, Dual (Psychiatry)”/OR (con-
current$ adj3 disorder$).mp. OR (dual$ adj3 diag$).mp.
OR (alcohol$ adj3 abus$).mp. OR (alcohol$ adj3 depend
$).mp. OR (substance$ adj3 abus$).mp. OR (substance$
adj3 depend$).mp. OR (drug$ adj3 abus$).mp. OR (drug
$ adj3 depend$).mp. OR addiction$.mp.] AND [exp Ab-
senteeism/OR exp Sick Leave/OR exp Return to Work/
OR exp Personnel Turnover/OR Social Welfare/OR
Public Assistance/OR exp Insurance Disability/OR exp
Insurance Benefits/OR exp Salaries/OR exp Fringe
Benefits/OR exp Social Security/OR exp Retirement/
OR (sick$ adj3 day$).mp. OR (illness$ adj3 leave$).mp.
OR (disabilit$ adj3 leave$).mp. OR (short term disabilit$).
mp. OR (long term disabilit$).mp. OR (work$ adj3 ab-
sence$).mp. OR (return$ to work$).mp. OR (work$ adj3
turnover$).mp. OR (employ$ adj3 turnover$).mp. OR (dis-
abilit$ benefit$).mp. OR (employ$ benefit$).mp. OR (work
$ benefit$).mp. OR (sick$ benefit$).mp. OR (incapacit$
benefit$).mp. OR (social$ welfar$).mp. OR (public$ assis-
tanc$).mp. OR (insurance$ disabilit$).mp. OR (insurance$
benefit$).mp. OR (old$ age$ assistanc$).mp. OR (social$
securit$).mp. OR retire$.mp.] AND [sn.fs. OR ep.fs. OR
preval$.mp. OR incid$.mp. OR statistic$.mp. OR exp
Epidemiologic Methods/].
Database: PsycINFO
Search Terms: [exp Mental Disorders/OR exp Psychiatric
patients/OR (mental adj3 disorder$).mp. OR (mental$
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http://www.biomedcentral.com/1471-2458/14/205adj3 ill$).mp. OR (psychiatric$ adj3 disorder$).mp. OR
(psychiatric$ adj3 ill$).mp. OR exp Drug Abuse/OR exp
Drug Addiction/OR exp Drug Dependency/OR exp Alco-
hol Abuse/OR exp Addiction/ OR exp Dual Diagnosis/OR
(concurrent$ adj3 disorder$).mp. OR (dual$ adj3 diag$).
mp. OR (alcohol$ adj3 abus$).mp. OR (alcohol$ adj3
depend$).mp. OR 321$.cc.[psychological disorders class
code] OR 3233.cc.[Substance abuse & addic class code]
OR (substance$ adj3 depend$).mp. OR (drug$ adj3 abus
$).mp. OR (drug$ adj3 depend$).mp. OR addiction$.
mp.] AND [exp Employee Absenteeism/OR (absenteeism
$).mp. OR exp Employee Leave Benefits/OR exp Reem-
ployment/OR exp Employee Turnover/OR (social welfar
$).mp. OR exp Insurance/OR exp Salaries/OR exp em-
ployee benefits/OR exp Social Security/OR exp Retire-
ment/OR (sick$ adj3 day$).mp. OR (illness$ adj3 leave
$).mp. OR (disabilit$ adj3 leave$).mp. OR (short term
disabilit$).mp. OR (long term disabilit$).mp. OR (work
$ adj3 absence$).mp. OR (return$ to work$).mp. OR
(work$ adj3 turnover$).mp. OR (employ$ adj3 turn-
over$).mp. OR (disabilit$ benefit$).mp. OR (employ$
benefit$).mp. OR (work$ benefit$).mp. OR (sick$ benefit
$).mp. OR (incapacit$ benefit$).mp. OR (social$ welfar$).
mp. OR (public$ assistanc$).mp. OR (insurance$ disabilit
$).mp. OR (insurance$ benefit$).mp. OR (old$ age$
assistanc$).mp. OR (social$ securit$).mp. OR retire$.
mp.] AND [preval$.mp. OR incid$.mp. OR statistic$.
mp. OR exp Epidemiology/OR ext Data collection/OR
epidemiolog$.mp. OR (data collection$).mp. OR survey
$.mp. OR questionnair$.mp.].
Database: Econlit
Search Terms: [mental disorder* OR mental disorder*
OR mental ill* OR psychiatric* OR concurrent* disorder*
OR dual* diag* OR alcohol* OR substance* abus* OR sub-
stance* depend* OR drug* abus* OR drug* depend* OR
addic*] AND [absent* OR sick* OR ill* OR disabilit* leav*
OR short term disabilit* OR long term disabilit* OR
work* OR absence* OR return* to work* OR work*
turnover* OR employ* OR benefit* OR welfar* OR pub-
lic* assistanc* OR insurance* OR old* age* assistanc*
OR social securit* OR retire*].
Database: Web of Science
Search Terms: [mental disorder* OR mental ill* OR psy-
chiatric* disorder* OR psychiatric* ill* OR concurrent*
disorder* OR dual* diag* OR alcohol* abus* OR alcohol*
depend* OR substance* abus* OR substance* depend*
OR drug* abus* OR drug* depend* OR addiction*] AND
[absenteeism* OR sick* day* OR illness* leave* OR dis-
abilit* leav* OR short term disabilit* OR long term dis-
abilit* OR work* absence* OR return* to work* OR work*
turnover* OR employ* turnover* OR disabilit* benefit* OR
employ* benefit* OR work* benefit* OR sick* benefit* ORincapacit* benefit* OR social* welfar* OR public* assis-
tanc* OR insurance* disabilit* OR insurance* benefit* OR
old* age* assistanc* OR social securit* OR retire*] AND
[preval* OR incid* OR statistic* OR epidemiolog* OR data
collection* OR survey* OR questionnair*].
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Additional file 1: Table S1. Quality Assessment Checklist. The
additional file contains the quality checklist criteria used to determine the
quality of papers being analyzed for the systematic literature review and
the scores for each article.
Additional file 2: PRISMA 2009 Checklist.
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